Flow imaging microscopy for protein particle analysis - A comparative evaluation of four different analytical instruments

AAPS Journal

Volumn 15, Issue 4, 2013, Pages 1200-1211

  Zölls, Sarah ^a,b   Weinbuch, Daniel ^a,c   Wiggenhorn, Michael ^a   Winter, Gerhard ^b   Friess, Wolfgang ^b   Jiskoot, Wim ^c   Hawe, Andrea ^a  

^a Coriolis Pharma ^*  (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

flow imaging; particle analysis; protein particles; silicone oil droplets; subvisible particles

Indexed keywords

MONOCLONAL ANTIBODY; SILICONE OIL;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; FLOW CYTOMETER; FLOW IMAGING MICROSCOPY; IMAGE QUALITY; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MICRO FLOW IMAGING 4100; MICRO FLOW IMAGING 5200; MICROSCOPE VS1; MICROSCOPY; PARTICLE SIZE; PROTEIN ANALYSIS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FLOW CYTOMETRY; MICROSCOPY; PARTICLE SIZE;

EID: 84888011585     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-013-9522-2     Document Type: Article

References (27)

1. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G, et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci. 2009;98:1201-5.
2. Carpenter J, Cherney B, Lubinecki A, Ma S, Marszal E, Mire-Sluis A, et al. Meeting report on protein particles and immunogenicity of therapeutic proteins: filling in the gaps in risk evaluation and mitigation. Biologicals. 2010;38:602-11.
3. Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler H-C, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101:895-913.
4. Narhi LO, Schmit J, Bechtold-Peters K, Sharma D. Classification of protein aggregates. J Pharm Sci. 2012;101:493-8.
5. Rosenberg AS. Effects of protein aggregates: an immunologic perspective. AAPS J. 2006;8:E501-7.
6. Ph.Eur. 2.9.19, Pharmacopoea Europaea, 7th ed. 2010. Particulate contamination: sub-visible particles. European Directorate for the Quality of Medicine (EDQM).
7. USP<788>, United States Pharmacopeia, USP35-NF30, 2012. Particulate matter in injections. United States Pharmacopeial convention.
8. Kirshner S. Regulatory expectations for analysis of aggregates and particles. Talk at Workshop on Protein Aggregation and Immunogenicity, Breckenridge, Colorado. 12 July 2012.
9. Food US, Administration D. Guidance for industry. Immunogenicity assessment for therapeutic protein products (draft guidance). Silver Spring, MD, USA: FDA; 2013.
10. Zölls S, Tantipolphan R, Wiggenhorn M, Winter G, Jiskoot W, Friess W, et al. Particles in therapeutic protein formulations, part 1: overview of analytical methods. J Pharm Sci. 2012;101:914-35.
11. Burg TP, Godin M, Knudsen SM, Shen W, Carlson G, Foster JS, et al. Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature. 2007;446:1066-9.
12. Narhi LO. AAPS update on USP expert committee for sub-visible particle analysis. Newsletter of the AAPS Aggregation and Biological Relevance Focus Group. 2012;3(2).
13. Demeule B, Messick S, Shire SJ, Liu J. Characterization of particles in protein solutions: reaching the limits of current technologies. AAPS J. 2010;12:708-15.
14. Sharma DK, Oma P, Pollo MJ, Sukumar M. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. J Pharm Sci. 2010;99:2628-42.
15. Wuchner K, Büchler J, Spycher R, Dalmonte P, Volkin DB. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. J Pharm Sci. 2010;99:3343-61.
16. Joubert MK, Luo Q, Nashed-Samuel Y, Wypych J, Narhi LO. Classification and characterization of therapeutic antibody aggregates. JBC. 2011;286:25118-33.
17. Barnard JG, Babcock K, Carpenter JF. Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity. J Pharm Sci. 2012;102:915-28.
18. Barnard JG, Singh S, Randolph TW, Carpenter JF. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway. J Pharm Sci. 2011;100:492-503.
19. Patel AR, Lau D, Liu J. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator. Anal Chem. 2012;84(15):6833-40.
20. Sharma DK, King D, Oma P, Merchant C. Micro-flow imaging: flow microscopy applied to sub-visible particulate analysis in protein formulations. AAPS J. 2010;12:455-64.
21. Brown L. Characterizing biologics using dynamic imaging particle analysis. BioPharm Int. 2011;24(8):s4-9.
22. Weinbuch D, Zölls S, Wiggenhorn M, Friess W, Winter G, Jiskoot W, et al. Micro-flow imaging and resonant mass measurement (Archimedes) - complimentary methods to quantitatively differentiate protein particles and silicone oil droplets. J Pharm Sci. 2013;102:2152-65.
23. Strehl R, Rombach-Riegraf V, Diez M, Egodage K, Bluemel M, Jeschke M, et al. Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: a novel multiparametric image filter for sub-visible particles in microflow imaging analysis. Pharm Res. 2012;29(2):594-602.
24. Sharma BDK, Oma P, Krishnan S. Silicone microdroplets in protein formulations - detection and enumeration. Pharm Technol. 2009;33:74-9.
25. Huang C-T, Sharma D, Oma P, Krishnamurthy R. Quantitation of protein particles in parenteral solutions using micro-flow imaging. J Pharm Sci. 2009;98:3058-71.
26. Zölls S, Gregoritza M, Tantipolphan R, Wiggenhorn M, Winter G, Friess W, et al. How subvisible particles become invisible - relevance of the refractive index for protein particle analysis. J Pharm Sci. 2013;102:1434-46.
27. Wilson GA, Manning MC. Flow imaging: moving toward best practices for subvisible particle quantitation in protein products. J Pharm Sci. 2013;102:1133-4.